Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bodell, W. J.
Right arrow Articles by Pongracz, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodell, W. J.
Right arrow Articles by Pongracz, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 437-443, Copyright © 1998 by Oxford University Press


ARTICLES

Oxidation of eugenol to form DNA adducts and 8-hydroxy-2'- deoxyguanosine: role of quinone methide derivative in DNA adduct formation

WJ Bodell, Q Ye, DN Pathak and K Pongracz
Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco 94143-0806, USA. bodell@itsa.ucsf.edu

We have investigated the activation of eugenol to form DNA adducts and oxidative base damage. Treatment of myeloperoxidase containing HL-60 cells with eugenol, produced a dose-dependent formation of three DNA adducts as detected with P1-enhanced 32P-post-labeling. Incubation of HL-60 cells with the combination of 100 microM eugenol and 100 microM H2O2 potentiated the levels of DNA adduct in HL-60 cells by 14-fold, which suggests peroxidase activation in adduct formation. In vitro activation of eugenol with either horseradish peroxidase or myeloperoxidase and H2O2 produced three DNA adducts that were inhibited by the addition of either ascorbic acid or glutathione, by 66 and 90%, respectively. The DNA adducts formed in HL-60 cells treated with eugenol were the same as those formed by in vitro peroxidase activation. In addition to adduct formation, peroxidase activation of eugenol produced a 2- to 3-fold increase in the level of oxidative base damage. Eugenol quinone methide was prepared by Ag(I)oxide oxidation of eugenol. Peroxidase activation of eugenol gave a product that had the same UV spectrum as eugenol quinone methide, which suggests that it was one of the products. Reaction of eugenol quinone methide with either DNA or deoxyguanosine-3'-phosphate produced two principal adducts (2 and 4). When DNA adduct 2 formed by incubation of eugenol quinone methide with deoxyguanosine-3'-phosphate was compared with DNA 2 adduct formed in HL-60 cells treated with eugenol results demonstrated that they were the same. This suggests that eugenol quinone methide is one of the reactive intermediates leading to DNA adduct formation in cells. Activation of eugenol with 10 microM copper sulfate resulted in the production of one principal (2) and several minor adducts. DNA adduct 2 formed by activation of eugenol with copper sulfate was the same as DNA adduct 2 formed by either peroxidase activation of eugenol or by reactions with eugenol quinone methide, which indicates that the reactive intermediates generated by these activation systems were similar. Copper sulfate produced a 95-fold increase in the level of oxidative base damage, which was significantly inhibited by the addition of either bathocuproinedisulphonic acid or catalase. The formation of oxidative base damage was consistent with a Fenton reaction mechanism. Our results demonstrate that eugenol can be activated to form both DNA adducts and oxidative base damage. We propose that the formation of this DNA damage may contribute to the observed toxic properties of eugenol.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. S. Kalgutkar, D. K. Dalvie, J. Aubrecht, E. B. Smith, S. L. Coffing, J. R. Cheung, C. Vage, M. E. Lame, P. Chiang, K. F. McClure, et al.
Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation
Drug Metab. Dispos., June 1, 2007; 35(6): 848 - 858.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Maralhas, A. Monteiro, C. Martins, M. Kranendonk, A. Laires, J. Rueff, and A. S. Rodrigues
Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol
Mutagenesis, May 1, 2006; 21(3): 199 - 204.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-H. Lin, J. Nakamura, S. Yamaguchi, P. B. Upton, D. K. La, and J. A. Swenberg
Oxidative damage and direct adducts in calf thymus DNA induced by the pentachlorophenol metabolites, tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone
Carcinogenesis, April 1, 2001; 22(4): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-H. Lin, J. Nakamura, S. Yamaguchi, D. K. La, P. B. Upton, and J. A. Swenberg
Induction of direct adducts, apurinic/apyrimidinic sites and oxidized bases in nuclear DNA of human HeLa S3 tumor cells by tetrachlorohydroquinone
Carcinogenesis, April 1, 2001; 22(4): 635 - 639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. H. H. van den Heuvel, M. W. Fraaije, A. Mattevi, and W. J. H. van Berkel
Asp-170 Is Crucial for the Redox Properties of Vanillyl-alcohol Oxidase
J. Biol. Chem., May 12, 2000; 275(20): 14799 - 14808.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. J. Duell, J. K. Wiencke, T.-J. Cheng, A. Varkonyi, Z. F. Zuo, T. D. S. Ashok, E. J. Mark, J. C. Wain, D. C. Christiani, and K. T. Kelsey
Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells
Carcinogenesis, May 1, 2000; 21(5): 965 - 971.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.